Patents by Inventor Erich Fauland

Erich Fauland has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4436742
    Abstract: New amine derivatives of 4-hydroxy-2,1,3-benzthiadiazoles of the formula: ##STR1## wherein R is straight-chained or branched alkyl and the pharmacologically compatible salts thereof, that are markedly effected as inhibitors of adrenogenic .beta.-receptors and thus useful for the treatment and prophylaxis of cardiac and circulatory diseases.
    Type: Grant
    Filed: November 20, 1980
    Date of Patent: March 13, 1984
    Assignee: Boehringer Mannheim GmbH
    Inventors: Erich Fauland, Wolfgang Kampe, Kurt Stach, Wolfgang Bartsch, Egon Roesch
  • Patent number: 4370323
    Abstract: A 2-cyanoaziridinyl-(1)-2-substituted-aziridinyl-(1)-methane ##STR1## wherein R is a nitrile or carbamoyl group, andR.sub.1 and R.sub.2 each independently is a hydrogen atom, an aliphatic hydrocarbon radical containing up to 10 carbon atoms optionally substituted by hydroxyl, alkoxy, amino, alkylamino, dialkylamino, alkoxycarbonyl, cyano, 1, 2 or 3 halogens, cycloalkyl, phenyl or phenoxy; nitrile, carboxyl, alkoxycarbonyl or optionally hydrogenated monocyclic heteroaryl or phenyl optionally substituted by alkyl, alkoxy, hydroxy, alkoxcarbonyl, dialkylamino, alkylthio, trifluoromethyl, nitro, carbamoyl, nitrile, sulphonamido, hydroxyalkyl, methylenedioxy, or halogen; or R.sub.1 and R.sub.2, together with the carbon atom to which they are attached, form a ring containing up to 8 ring members of which at least one may be oxygen, sulphur, SO, SO.sub.
    Type: Grant
    Filed: March 9, 1977
    Date of Patent: January 25, 1983
    Assignee: Boehringer Mannheim GmbH
    Inventors: Wolfgang Kampe, Max Thiel, Erich Fauland, Uwe Bicker, Gottfried Hebold
  • Patent number: 4224438
    Abstract: Adenosine-5'-carboxylic acid derivatives of the general formula: ##STR1## wherein Z is two hydrogen atoms or a divalent lower alkylidene radical, ##STR2## R is an aliphatic or arylaliphatic radical, and R.sub.1 and R.sub.2 are independently a hydrogen, hydroxyl, amino, lower alkyl, lower alkenyl, optionally N-alkylated lower aminoalkyl, cycloalkyl, hydroxyalkyl or piperidinyl radical, orR.sub.1 and R.sub.2 taken together are a divalent ethylene radical containing 4-7 carbon atoms optionally interrupted by an oxygen or sulfur atom or by an imino, alkylimino or arylimino radical or a pharmacologically compatible salt thereof.The esters surprisingly can be prepared by esterifying the acid in the presence of sulfuric acid without hydrolyzing the sugar group. While the esters have some activity, they can be used to make the amides which are characterized by marked coronary activity.
    Type: Grant
    Filed: July 9, 1971
    Date of Patent: September 23, 1980
    Assignee: Boehringer Mannheim GmbH
    Inventors: Erich Fauland, Wolfgang Kampe, Max Thiel, Karl Dietmann, Wolfgang Juhran
  • Patent number: 4016262
    Abstract: N(6)-disubstituted adenosine compounds of the formula: ##STR1## wherein R.sub.1 is alkenyl, cycloalkenyl or cycloalkenyl-alkyl; andR.sub.2 is alkenyl, cycloalkenyl, straight or branched-chain alkyl, cycloalkyl, bicycloalkyl, alkyl-cycloalkyl, or alkyl-bicycloalkyl;And the pharmacologically compatible salts thereof; exhibit outstanding anti-lipolytic, anti-hyperlipaemic and anti-hypercholesterolaemic action.
    Type: Grant
    Filed: May 30, 1975
    Date of Patent: April 5, 1977
    Assignee: Boehringer Mannheim G.m.b.H.
    Inventors: Erich Fauland, Wolfgang Kampe, Kurt Stach, deceased, by Werner Plattner, executor, Harald Stork, Karl Dietmann
  • Patent number: 3982012
    Abstract: New 4-hydroxy-benzimidazole compounds of the formula: ##EQU1## wherein R.sub.1 is straight-chained or branched alkyl andR.sub.2 is hydrogen atom or lower alkylAnd the pharmacologically compatible salts thereof; are outstandingly effective in the treatment and prophylaxis of cardiac and circulatory diseases, and provide substantially greater margins of safety than prior art adrenergic .beta.-receptor inhibitors.
    Type: Grant
    Filed: June 10, 1975
    Date of Patent: September 21, 1976
    Assignee: Boehringer Mannheim G.m.b.H.
    Inventors: Erich Fauland, Wolfgang Kampe, Max Thiel, Wolfgang Bartsch, Wolfgang Schaumann
  • Patent number: 3966916
    Abstract: New N(6)-disubstituted adenosine compound of the formula ##SPC1##WhereinR.sub.1 is lower alkyl substituted by at least one of hydroxyl, alkoxy or acyloxy; or is cycloalkyl or straight-chained or branched lower alkenyl;R.sub.2 and R.sub.3 are hydrogen, halogen, or nitro or lower alkyl, alkoxy or alkylthio andR.sub.4 is hydrogen or acyl; when R.sub.4 is acyl, R.sub.1 can also be lower alkyl;And the pharmacologicaly compatible salts thereof; exhibits shown anti-lipolytic, anti-hyperlipaemic and anti-hypercholesterolaemic action.
    Type: Grant
    Filed: November 21, 1974
    Date of Patent: June 29, 1976
    Assignee: Boehringer Mannheim G.m.b.H.
    Inventors: Wolfgang Kampe, Erich Fauland, Kurt Stach, Harald Stork, Felix Helmut Schmidt